Multitrend Indo Tbk vs Merck Tbk. — how do they compare? Multitrend Indo Tbk trades at Rp174 (market cap 485.32B, 589.3K 24h volume), while Merck Tbk. trades at Rp3,740 (market cap 1.68T, 22.8K 24h volume). The key difference: Merck Tbk. is far larger — about 3.5× Multitrend Indo Tbk's market cap, and Multitrend Indo Tbk is more actively traded (589.3K versus 22.8K). Which is the better fit depends on your goals.
| BABY | MERK | |
|---|---|---|
Market Cap | 485.32B | 1.68T |
Volume | 589.3K | 22.8K |
Lot | 5.89K | 228 |
Turnover | 101.82M | 82.9M |
Average Price | 172.78 | 3,636.14 |
Value | 101.82M | 82.9M |
Indicative Equilibrium Price | 174 | 3,520 |
Indicative Equilibrium Volume | 60 | 60 |
Trailing returns across standard periods
Latest headlines on both assets
PT Multitrend Indo Tbk ("Company") was established based on notary deed Drs. Wijanto Suwongso, SH, No. 20 dated September 7, 2004 and has beeen approved by the Ministry of Justice and Human Rights of Republic of Indonesia in its Decision Decree No. C-25996 HT.01.01.TH.2004 dated October 19 2004, and announced in the State Gazette No. 96 dated November 30, 2004, Supplement to the State Gazette of the Republic of Indonesia No. 11708. The Company started its commercial operations in 2004. PT Kanmo Retailindo are the parent entity and the ultimate parent of the Company.
Read more on BABY →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →